Literature DB >> 29903508

Rapid TEG efficiently guides hemostatic resuscitation in trauma patients.

Julia R Coleman1, Ernest E Moore2, Michael P Chapman3, Anirban Banerjee3, Christopher C Silliman3, Arsen Ghasabyan4, James Chandler4, Jason M Samuels3, Angela Sauaia3.   

Abstract

BACKGROUND: Several thrombelastography functional assays have been developed to guide transfusion in injured patients, but how this acceleration of thrombelastography affects its ability to predict massive transfusion is unknown. The objective of this study is to compare citrated native, citrated kaolin, and citrated rapid thromboelastographies for their prediction of massive transfusion after trauma. We hypothesized that citrated native thrombelastography best predicts massive transfusion.
METHODS: Data were collected as part of a prospective study of trauma activation patients. All patients received citrated native, citrated kaolin, or citrated rapid thromboelastographies. Logistic regression was used to assess the predictive performance of different thrombelastography assays for massive transfusion.
RESULTS: Measurements for all three TEG activating systems was available for 343 patients; 57 (16.6%) required a massive transfusion. Compared to citrated rapid thromboelastographies, citrated kaolin thromboelastographies performed better for activated clotting time/rapid and citrated native thromboelastographies for maximum amplitude and angle. Yet, the 95% confidence intervals overlapped considerably, suggesting the citrated rapid thromboelastographies produced comparable results to the other assays for activated clotting time/reaction time, maximum amplitude, and angle.
CONCLUSION: There was substantial overlap in the performance of the different thrombelastography assays, suggesting citrated rapid thrombelastography is a quick and effective method to guide hemostatic resuscitation in trauma patients and does not perform inferiorly to the citrated native or citrated kaolin thrombelastography despite the addition of activation factors. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29903508      PMCID: PMC6108915          DOI: 10.1016/j.surg.2018.04.029

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

1.  THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.

Authors:  R M HARDISTY; R A HUTTON
Journal:  Br J Haematol       Date:  1965-05       Impact factor: 6.998

2.  A comparison of the Thrombelastograph and the ROTEM.

Authors:  Vance G Nielsen
Journal:  Blood Coagul Fibrinolysis       Date:  2007-04       Impact factor: 1.276

3.  Massive transfusion policies at trauma centers participating in the American College of Surgeons Trauma Quality Improvement Program.

Authors:  Maraya N Camazine; Mark R Hemmila; Julie C Leonard; Rachel A Jacobs; Jennifer A Horst; Rosemary A Kozar; Grant V Bochicchio; Avery B Nathens; Henry M Cryer; Philip C Spinella
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

4.  Kaolin activated thromboelastography can result in false positive fibrinolytic trace.

Authors:  M Durila
Journal:  Anaesth Intensive Care       Date:  2011-07       Impact factor: 1.669

5.  Early diagnosis of clinically significant hyperfibrinolysis using thrombelastography velocity curves.

Authors:  Matthew J Pommerening; Michael D Goodman; Danny L Farley; Jessica C Cardenas; Jeanette Podbielski; Nena Matijevic; Charles E Wade; John B Holcomb; Bryan A Cotton
Journal:  J Am Coll Surg       Date:  2014-10-08       Impact factor: 6.113

6.  Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission.

Authors:  Bryan A Cotton; Gabriel Faz; Quinton M Hatch; Zayde A Radwan; Jeanette Podbielski; Charles Wade; Rosemary A Kozar; John B Holcomb
Journal:  J Trauma       Date:  2011-08

7.  Rapid thrombelastography thresholds for goal-directed resuscitation of patients at risk for massive transfusion.

Authors:  Peter M Einersen; Ernest E Moore; Michael P Chapman; Hunter B Moore; Eduardo Gonzalez; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2017-01       Impact factor: 3.313

8.  Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?

Authors:  Karim Brohi; Mitchell J Cohen; Michael T Ganter; Michael A Matthay; Robert C Mackersie; Jean-François Pittet
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma.

Authors:  Hunter B Moore; Ernest E Moore; Theresa L Chin; Eduardo Gonzalez; Michael P Chapman; Carson B Walker; Angela Sauaia; Anirban Banerjee
Journal:  Surgery       Date:  2014-06-02       Impact factor: 3.982

10.  Epidemiology of trauma deaths: a reassessment.

Authors:  A Sauaia; F A Moore; E E Moore; K S Moser; R Brennan; R A Read; P T Pons
Journal:  J Trauma       Date:  1995-02
View more
  9 in total

1.  Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

2.  Multiple electrode aggregometry and thromboelastography in thrombocytopenic patients with haematological malignancies.

Authors:  Elin N Opheim; Torunn O Apelseth; Simon J Stanworth; Geir E Eide; Tor Hervig
Journal:  Blood Transfus       Date:  2018-12-13       Impact factor: 3.443

3.  Trauma Resuscitation Consideration: Sex Matters.

Authors:  Julia R Coleman; Ernest E Moore; Jason M Samuels; Mitchell J Cohen; Angela Sauaia; Joshua J Sumislawski; Arsen Ghasabyan; James G Chandler; Anirban Banerjee; Christopher C Silliman; Erik D Peltz
Journal:  J Am Coll Surg       Date:  2019-01-21       Impact factor: 6.113

4.  A clinical coagulopathy score concurrent with viscoelastic testing defines opportunities to improve hemostatic resuscitation and enhance blood product utilization during liver transplantation.

Authors:  Alexander C Schulick; Hunter B Moore; Carson B Walker; Hillary Yaffe; James J Pomposelli; Fareed Azam; Michael Wachs; Thomas Bak; Peter Kennealey; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Michael P Chapman; Elizabeth A Pomfret; Trevor L Nydam
Journal:  Am J Surg       Date:  2020-09-01       Impact factor: 2.565

5.  Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia.

Authors:  Philip Crispin; Sarah Hicks; Lucy A Coupland; Sidra Ali; Elizabeth E Gardiner
Journal:  EJHaem       Date:  2021-12-08

6.  Nanoporous and nano thickness film-forming bioactive composition for biomedical applications.

Authors:  Naga Thirumalesh Chevala; Lalit Kumar; Vimal Veetilvalappil; Aranjani Jesil Mathew; Bemma Paonam; Ganesh Mohan; Shamee Shastry; Krishnan Balasubramanian; C Mallikarjuna Rao
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

7.  It's sooner than you think: Blunt solid organ injury patients are already hypercoagulable upon hospital admission - Results of a bi-institutional, prospective study.

Authors:  Julia R Coleman; Annika B Kay; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Sarah Majercik; Mitchell J Cohen; Thomas White; Fredric M Pieracci
Journal:  Am J Surg       Date:  2019-09-10       Impact factor: 2.565

8.  Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF.

Authors:  Madhumita Premkumar; Rohit Mehtani; Smita Divyaveer; Kamal Kajal; Anand V Kulkarni; Syed Ahmed; Harmanpreet Kaur; Harpreet Kaur; Radhakrishna Dhiman; Ajay Duseja; Arka De
Journal:  J Clin Transl Hepatol       Date:  2021-02-18

9.  Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.

Authors:  Nathan Dow; Julia R Coleman; Hunter Moore; Zachary T Osborn; Adrian M Sackheim; Grant Hennig; Saulius Butenas; Mark T Nelson; Ernest E Moore; Kalev Freeman
Journal:  J Trauma Acute Care Surg       Date:  2020-02       Impact factor: 3.697

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.